(¿Â¶óÀÎ) Á¦47Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦7Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2 : 2021-06-18±³À°ÀÏÀÚ : 2021-06-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°(½Ç½Ã°£ È»ó °ÀÇ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) Á¦47Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦7Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 2ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer2@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 15 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í 1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 6¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 3¸¸¿ø / 3) ¾÷ü ¹× ¾÷ü¿¬±¸¼Ò: 6¸¸¿ø 2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 9¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 4¸¸¿ø / 3) ¾÷ü ¹× ¾÷ü¿¬±¸¼Ò: 9¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-18 Room A 09:40~10:20 Dissecting tumor evolution Tyler E. Jacks(Koch Institute for Integrative Cancer Research at MIT)
ÈÞ½Ä 06-18 10:20~10:30 ÈÞ½Ä ()
±³À°½Ã°£ 06-18 Room A 10:30~10:55 Addressing emerging challenges in cell therapy of cancer Dario Campana(National University of Singapore Yong Loo Lin School of Medicine)
±³À°½Ã°£ 06-18 Room A 10:55~11:20 Effects of sequential and timely combination of a cancer nanovaccine with immune checkpoint blockade on tumor control Àü»ó¿ë(KAIST)
±³À°½Ã°£ 06-18 Room A 11:20~11:45 Cancer immunotherapy targeting the tumor microenvironment by recombinant cytokine and bispecific antibody À̽¿ì(POSTECH)
±³À°½Ã°£ 06-18 Room A 11:45~12:10 Reprogrammed oncolytic adenovirus as cancer immunotherapeutic À±Ã¤¿Á(ÇѾç´ë)
±³À°½Ã°£ 06-18 Room B 10:30~10:55 Fluorescent-guided cancer surgery Takeaki Ishizawa(University of Tokyo)
±³À°½Ã°£ 06-18 Room B 10:55~11:20 Intraoperative radiotherapy for pancreas cancer ¹ÚÁؼº(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 06-18 Room B 11:20~11:45 AI prediction model for clinical outcomes of colorectal cancer ¹ÚÁö¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06-18 Room B 11:45~12:10 AI Imaging analysis of surgical video Á¤Ã¢¿í(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06-18 Room C 10:30~10:55 Proton therapy: What we know and do not know ¿Àµ¿·Ä(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-18 Room C 10:55~11:20 Introduction of FLASH radiotherapy: KIRAMS experiences Àå¿øÀÏ(¿øÀڷº´¿ø)
±³À°½Ã°£ 06-18 Room C 11:20~11:45 Current technical challenges for FLASH proton therapy ÀÓ¿µ°æ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06-18 Room C 11:45~12:10 Synchrotron X-ray FLASH therapy ±èÁ¾±â(´ë±¸°¡Å縯ÀÇ´ë)
½Ä»ç 06-18 12:10~12:50 ½Ä»ç ()
±³À°½Ã°£ 06-18 Room A 12:50~13:10 To be announced ÇÑÇý¼÷(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06-18 Room B 12:50~13:10 TAS-102, for better treatment outcomes in metastatic colorectal cancer ¹ü½ÂÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-18 Room C 12:50~13:10 IMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC ÀÌ´ëÈ£(¿ï»êÀÇ´ë)
ÈÞ½Ä 06-18 13:10~13:20 ÈÞ½Ä ()
±³À°½Ã°£ 06-18 Room A+B 13:20~13:45 Recent updates in COVID-19 treatment and vaccines ÃÖÆò±Õ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-18 Room A+B 13:45~14:10 Special risk of COVID-19 in cancer surgery Vivian E. Strong(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 06-18 Room A+B 14:10~14:35 COVID-19 vaccination recommendation for cancer patients ¹Ú¿¬Èñ(¼º±Õ°üÀÇ´ë)
Åä·Ð 06-18 Room A+B 14:35~15:00 Panel Discussion: Influence of COVID-19 on cancer care in Asian countries ()
±³À°½Ã°£ 06-18 Room C 13:20~13:45 Diagnosis and molecular classification of endometrial cancer ±èÈ¿Áø(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06-18 Room C 13:45~14:10 Treatment decision according to the integrated molecular markers ±è¹Ì°æ(ÀÌ´ë¸ñµ¿º´¿ø)
±³À°½Ã°£ 06-18 Room C 14:10~14:35 Immune checkpoint inhibitor for recurrent setting ¹®¿ëÈ(Â÷ÀÇ´ë)
±³À°½Ã°£ 06-18 Room C 14:35~15:00 Immune checkpoint blockade combination in endometrial cancer È«ÁøÈ(°í·ÁÀÇ´ë)
ÈÞ½Ä 06-18 15:00~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 06-18 Room C 15:10~15:35 [º¸°Çº¹ÁöºÎ] K-Cancer ÅëÇÕ ºòµ¥ÀÌÅÍ ±¸Ãà ¹æ¾È°ú Àü·« °ÁØ(º¸°Çº¹ÁöºÎ)
±³À°½Ã°£ 06-18 Room C 15:35~16:00 [±¹¸³¾Ï¼¾ÅÍ] ¾Ï ºòµ¥ÀÌÅÍ È°¿ë ÀÎÇÁ¶ó ±¸Ãà »ç¾÷ ÇöȲ Ãֱͼ±(±¹¸³¾Ï¼¾Åͱ¹Á¦¾Ï´ëÇпø´ëÇб³)
±³À°½Ã°£ 06-18 Room C 16:00~16:25 [±¹¹Î°Ç°º¸Çè°ø´Ü] ¾Ï°ËÁø µ¥ÀÌÅÍ ÇöȲ ¹× È°¿ë ±èµ¿¿í(±¹¹Î°Ç°º¸Çè°ø´Ü)
±³À°½Ã°£ 06-18 Room C 16:25~16:50 [K-MASTER] ¾ÏÀ¯Àüü ¹× ÀÓ»ó µ¥ÀÌÅÍ °ø°³ ¹× °øÀ¯ ¹Ú°æÈ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-18 Room A 15:10~15:35 Molecular characterization of responders and nonresponders to anti-PD1 inhibitors in GC ÀÌÁö¿¬(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-18 Room A 15:35~16:00 Overcoming resistance to anti-HER2 therapy ±èÅ¿ë(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-18 Room A 16:00~16:25 Strategies to overcome therapeutic resistance in renal cell carcinoma ±èÀÎÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-18 Room A 16:25~16:50 Overcoming resistance to immunotherapy in combination with radiotherapy targeting the tumor microenvironment ÀåÁö¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-18 Room B 15:10~15:35 Basic principles of AI in cancer imaging ±èÈÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-18 Room B 15:35~16:00 AI in neuro-oncology imaging ¹ÚÁöÀº(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 06-18 Room B 16:00~16:25 AI approach in digital pathology Á¤¿ä¼Á(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-18 Room B 16:25~16:50 Whole-slide image analysis reveals quantitative landscape of tumor–immune microenvironment in colorectal cancers ¹èÁ¤¸ð(¼¿ï´ëº´¿ø)